MPWT
FULC icon

MassMutual Private Wealth & Trust’s Fulcrum Therapeutics FULC Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-581
Closed -$4.46K – 2432
2026
Q1 		$4.46K Buy
+581
New +$5.39K ﹤0.01% 1724

Other funds holding FULC

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

MassMutual Private Wealth & Trust's FULC Position: Q2 2026 in Review

MassMutual Private Wealth & Trust sold out of Fulcrum Therapeutics (FULC) in Q2 2026, closing a stake of 581 shares — an estimated $4.46K sold.

MassMutual Private Wealth & Trust first reported a position in FULC in Q1 2026 and held it in 1 quarter. The position peaked at $4.46K in Q1 2026. 40 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • MassMutual Private Wealth & Trust reported no remaining Fulcrum Therapeutics position as of Q2 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 581 Fulcrum Therapeutics shares in Q2 2026, an estimated $4.46K.
  • MassMutual Private Wealth & Trust first reported a position in Fulcrum Therapeutics in Q1 2026 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Fulcrum Therapeutics position peaked at $4.46K in Q1 2026.
  • 40 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.